Your browser doesn't support javascript.
loading
The Global, Regional, and National Burden of Adult Lip, Oral, and Pharyngeal Cancer in 204 Countries and Territories: A Systematic Analysis for the Global Burden of Disease Study 2019.
Cunha, Amanda Ramos da; Compton, Kelly; Xu, Rixing; Mishra, Rashmi; Drangsholt, Mark Thomas; Antunes, Jose Leopoldo Ferreira; Kerr, Alexander R; Acheson, Alistair R; Lu, Dan; Wallace, Lindsey E; Kocarnik, Jonathan M; Fu, Weijia; Dean, Frances E; Pennini, Alyssa; Henrikson, Hannah Jacqueline; Alam, Tahiya; Ababneh, Emad; Abd-Elsalam, Sherief; Abdoun, Meriem; Abidi, Hassan; Abubaker Ali, Hiwa; Abu-Gharbieh, Eman; Adane, Tigist Demssew; Addo, Isaac Yeboah; Ahmad, Aqeel; Ahmad, Sajjad; Ahmed Rashid, Tarik; Akonde, Maxwell; Al Hamad, Hanadi; Alahdab, Fares; Alimohamadi, Yousef; Alipour, Vahid; Al-Maweri, Sadeq Ali; Alsharif, Ubai; Ansari-Moghaddam, Alireza; Anwar, Sumadi Lukman; Anyasodor, Anayochukwu Edward; Arabloo, Jalal; Aravkin, Aleksandr Y; Aruleba, Raphael Taiwo; Asaad, Malke; Ashraf, Tahira; Athari, Seyyed Shamsadin; Attia, Sameh; Azadnajafabad, Sina; Azangou-Khyavy, Mohammadreza; Badar, Muhammad; Baghcheghi, Nayereh; Banach, Maciej; Bardhan, Mainak.
Afiliação
  • Cunha ARD; School of Public Health, University of São Paulo, São Paulo, Brazil.
  • Compton K; Institute for Health Metrics and Evaluation, University of Washington, Seattle.
  • Xu R; Institute for Health Metrics and Evaluation, University of Washington, Seattle.
  • Mishra R; Department of Data and Tooling, Sage Bionetworks, Seattle, Washington.
  • Drangsholt MT; Department of Oral Medicine, School of Dentistry, University of Washington, Seattle.
  • Antunes JLF; Department of Oral Medicine, School of Dentistry, University of Washington, Seattle.
  • Kerr AR; Oral Medicine Clinic, School of Dentistry, University of Washington, Seattle.
  • Acheson AR; School of Public Health, University of São Paulo, São Paulo, Brazil.
  • Lu D; Department of Oral and Maxillofacial Pathology, Radiology, and Medicine, College of Dentistry, New York University, New York, New York.
  • Wallace LE; Institute for Health Metrics and Evaluation, University of Washington, Seattle.
  • Kocarnik JM; Institute for Health Metrics and Evaluation, University of Washington, Seattle.
  • Fu W; Institute for Health Metrics and Evaluation, University of Washington, Seattle.
  • Dean FE; Institute for Health Metrics and Evaluation, University of Washington, Seattle.
  • Pennini A; Institute for Health Metrics and Evaluation, University of Washington, Seattle.
  • Henrikson HJ; Institute for Health Metrics and Evaluation, University of Washington, Seattle.
  • Alam T; Department of Mathematics, University of California, Berkeley.
  • Ababneh E; Institute for Health Metrics and Evaluation, University of Washington, Seattle.
  • Abd-Elsalam S; Institute for Health Metrics and Evaluation, University of Washington, Seattle.
  • Abdoun M; Department of Global Health, School of Public Health, Boston University, Boston, Massachusetts.
  • Abidi H; Institute for Health Metrics and Evaluation, University of Washington, Seattle.
  • Abubaker Ali H; Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio.
  • Abu-Gharbieh E; Tropical Medicine Department, Faculty of Medicine, Tanta University, Tanta, Egypt.
  • Adane TD; Department of Medicine, University of Setif Algeria, Setif, Algeria.
  • Addo IY; Laboratory Technology Sciences Department, Yasuj University of Medical Sciences, Yasuj, Iran.
  • Ahmad A; Department of Banking and Finance, University of Human Development, Sulaymaniyah, Iraq.
  • Ahmad S; Clinical Sciences Department, University of Sharjah, Sharjah, United Arab Emirates.
  • Ahmed Rashid T; Department of Clinical and Psychosocial Epidemiology, University of Groningen, Groningen, the Netherlands.
  • Akonde M; Centre for Social Research in Health, University of New South Wales, Sydney, New South Wales, Australia.
  • Al Hamad H; Quality and Systems Performance Unit, Cancer Institute NSW, Sydney, New South Wales, Australia.
  • Alahdab F; Department of Medical Biochemistry, Shaqra University, Shaqra, Saudi Arabia.
  • Alimohamadi Y; Department of Health and Biological Sciences, Abasyn University, Peshawar, Pakistan.
  • Alipour V; Department of Computer Science and Engineering, University of Kurdistan Hewler, Erbil, Iraq.
  • Al-Maweri SA; Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia.
  • Alsharif U; Geriatric and Long Term Care Department, Hamad Medical Corporation, Doha, Qatar.
  • Ansari-Moghaddam A; Rumailah Hospital, Hamad Medical Corporation, Doha, Qatar.
  • Anwar SL; Evidence-Based Practice Center Program, Mayo Clinic Foundation for Medical Education and Research, Rochester, Minnesota.
  • Anyasodor AE; Health Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
  • Arabloo J; Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran.
  • Aravkin AY; Department of Health Economics, Iran University of Medical Sciences, Tehran, Iran.
  • Aruleba RT; College of Dental Medicine, Qatar University, Doha, Qatar.
  • Asaad M; Dortmund Clinic, Dortmund, Germany.
  • Ashraf T; Department of Epidemiology and Biostatistics, Zahedan University of Medical Sciences, Zahedan, Iran.
  • Athari SS; Department of Surgery, Faculty of Medicine, Gadjah Mada University, Yogyakarta, Indonesia.
  • Attia S; School of Dentistry and Medical Sciences, Charles Sturt University, Orange, New South Wales, Australia.
  • Azadnajafabad S; Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran.
  • Azangou-Khyavy M; Institute for Health Metrics and Evaluation, University of Washington, Seattle.
  • Badar M; Department of Applied Mathematics, College of Arts & Sciences, University of Washington, Seattle.
  • Baghcheghi N; Department of Health Metrics Sciences, School of Medicine, University of Washington, Seattle.
  • Banach M; Department of Molecular and Cell Biology, University of Cape Town, Cape Town, South Africa.
  • Bardhan M; Department of Plastic Surgery, University of Texas, Houston.
JAMA Oncol ; 9(10): 1401-1416, 2023 Oct 01.
Article em En | MEDLINE | ID: mdl-37676656
ABSTRACT
Importance Lip, oral, and pharyngeal cancers are important contributors to cancer burden worldwide, and a comprehensive evaluation of their burden globally, regionally, and nationally is crucial for effective policy planning.

Objective:

To analyze the total and risk-attributable burden of lip and oral cavity cancer (LOC) and other pharyngeal cancer (OPC) for 204 countries and territories and by Socio-demographic Index (SDI) using 2019 Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study estimates. Evidence Review The incidence, mortality, and disability-adjusted life years (DALYs) due to LOC and OPC from 1990 to 2019 were estimated using GBD 2019 methods. The GBD 2019 comparative risk assessment framework was used to estimate the proportion of deaths and DALYs for LOC and OPC attributable to smoking, tobacco, and alcohol consumption in 2019.

Findings:

In 2019, 370 000 (95% uncertainty interval [UI], 338 000-401 000) cases and 199 000 (95% UI, 181 000-217 000) deaths for LOC and 167 000 (95% UI, 153 000-180 000) cases and 114 000 (95% UI, 103 000-126 000) deaths for OPC were estimated to occur globally, contributing 5.5 million (95% UI, 5.0-6.0 million) and 3.2 million (95% UI, 2.9-3.6 million) DALYs, respectively. From 1990 to 2019, low-middle and low SDI regions consistently showed the highest age-standardized mortality rates due to LOC and OPC, while the high SDI strata exhibited age-standardized incidence rates decreasing for LOC and increasing for OPC. Globally in 2019, smoking had the greatest contribution to risk-attributable OPC deaths for both sexes (55.8% [95% UI, 49.2%-62.0%] of all OPC deaths in male individuals and 17.4% [95% UI, 13.8%-21.2%] of all OPC deaths in female individuals). Smoking and alcohol both contributed to substantial LOC deaths globally among male individuals (42.3% [95% UI, 35.2%-48.6%] and 40.2% [95% UI, 33.3%-46.8%] of all risk-attributable cancer deaths, respectively), while chewing tobacco contributed to the greatest attributable LOC deaths among female individuals (27.6% [95% UI, 21.5%-33.8%]), driven by high risk-attributable burden in South and Southeast Asia. Conclusions and Relevance In this systematic analysis, disparities in LOC and OPC burden existed across the SDI spectrum, and a considerable percentage of burden was attributable to tobacco and alcohol use. These estimates can contribute to an understanding of the distribution and disparities in LOC and OPC burden globally and support cancer control planning efforts.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Faríngeas / Carga Global da Doença Tipo de estudo: Risk_factors_studies Aspecto: Patient_preference Limite: Adult / Female / Humans / Male Idioma: En Revista: JAMA Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Brasil

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Faríngeas / Carga Global da Doença Tipo de estudo: Risk_factors_studies Aspecto: Patient_preference Limite: Adult / Female / Humans / Male Idioma: En Revista: JAMA Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Brasil